Here’s whether Opko Health Inc. (OPK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 3-month momentum positive (+16.5%). Concerns: 50-day MA is falling (-0.42% over 10 days); RSI 77 — overbought, elevated pullback risk; declining volume on rally — weak conviction (0.59x 30d avg). Currently 14.4% off its 52-week high. Score: +1/7.
OPK is in a confirmed uptrend, trading above both its 50-day ($1.38) and 200-day ($1.29) moving averages. With an RSI of 77.4, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +7.3% compares to +20.5% for SPY (trailed the market by 13.2%).
$10,000 invested 1 year ago→ $10,725 today
vs. S&P 500 (SPY) — same period trailed market by 13.2%